{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:05:38Z","timestamp":1791223538310,"version":"4.1.0"},"reference-count":109,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.vaccine.2015.04.029","type":"journal-article","created":{"date-parts":[[2015,4,19]],"date-time":"2015-04-19T04:00:23Z","timestamp":1429416023000},"page":"C36-C41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":88,"special_numbering":"S3","title":["Live attenuated vaccines for invasive Salmonella infections"],"prefix":"10.1016","volume":"33","author":[{"given":"Sharon M.","family":"Tennant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myron M.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.04.029_bib0550","first-page":"957","article-title":"Vaccination against typhoid fever: present status","volume":"72","author":"Ivanoff","year":"1994","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0555","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/epirev\/mxj003","article-title":"Immunization to protect the US Armed Forces: heritage, current practice, and prospects","volume":"28","author":"Grabenstein","year":"2006","journal-title":"Epidemiol Rev"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0560","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.4161\/hv.29054","article-title":"Vaccines against invasive Salmonella disease: current status and future directions","volume":"10","author":"MacLennan","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0565","article-title":"Typhoid fever","author":"Wain","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0570","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1586\/14760584.2013.825450","article-title":"Increasing rates of Salmonella Paratyphi A and the current status of its vaccine development","volume":"12","author":"Sahastrabuddhe","year":"2013","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0575","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1016\/S0140-6736(11)61752-2","article-title":"Invasive non-typhoidal Salmonella disease: an emerging and neglected tropical disease in Africa","volume":"379","author":"Feasey","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0580","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1128\/CMR.17.2.311-322.2004","article-title":"Salmonella enterica serotype Choleraesuis: epidemiology, pathogenesis, clinical disease, and treatment","volume":"17","author":"Chiu","year":"2004","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0585","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1600-065X.2010.00970.x","article-title":"Immunology of gut mucosal vaccines","volume":"239","author":"Pasetti","year":"2011","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0590","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/MOG.0b013e32830d58be","article-title":"Oral immunization: an update","volume":"24","author":"Mestecky","year":"2008","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0595","doi-asserted-by":"crossref","first-page":"4376","DOI":"10.1016\/j.vaccine.2013.12.026","article-title":"The delicate balance in genetically engineering live vaccines","volume":"32","author":"Galen","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0600","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/0140-6736(90)92266-K","article-title":"Comparison of enteric-coated capsules and liquid formulation of Ty21a typhoid vaccine in randomised controlled field trial","volume":"336","author":"Levine","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0605","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1128\/IAI.61.3.1149-1151.1993","article-title":"Safety and immunogenicity of Salmonella typhi Ty21a vaccine in young Thai children","volume":"61","author":"Cryz","year":"1993","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0610","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/infdis\/166.2.451","article-title":"Safety and immunogenicity of Salmonella typhi Ty21a liquid formulation vaccine in 4- to 6-year-old Thai children","volume":"166","author":"Olanratmanee","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0615","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/infdis\/131.5.553","article-title":"Isolation and characterization of Gal E mutant Ty 21a of Salmonella typhi: a candidate strain for a live, oral typhoid vaccine","volume":"131","author":"Germanier","year":"1975","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0620","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ijmm.2008.09.003","article-title":"Genetic stability of vaccine strain Salmonella Typhi Ty21a over 25 years","volume":"299","author":"Kopecko","year":"2009","journal-title":"Int J Med Microbiol"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0625","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1128\/IAI.56.5.1326-1333.1988","article-title":"A galE via (Vi antigen-negative) mutant of Salmonella typhi Ty2 retains virulence in humans","volume":"56","author":"Hone","year":"1988","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0630","doi-asserted-by":"crossref","first-page":"6640","DOI":"10.1073\/pnas.120163297","article-title":"One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products","volume":"97","author":"Datsenko","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0635","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0378-1119(03)00585-7","article-title":"Gene replacement without selection: regulated suppression of amber mutations in Escherichia coli","volume":"311","author":"Herring","year":"2003","journal-title":"Gene"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0640","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1128\/IAI.60.2.536-541.1992","article-title":"Comparison of the safety and immunogenicity of delta aroC delta aroD and delta cya delta crp Salmonella typhi strains in adult volunteers","volume":"60","author":"Tacket","year":"1992","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0645","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1128\/IAI.65.2.452-456.1997","article-title":"Safety of live oral Salmonella typhi vaccine strains with deletions in htrA and aroC aroD and immune response in humans","volume":"65","author":"Tacket","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0650","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/291238a0","article-title":"Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines","volume":"291","author":"Hoiseth","year":"1981","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0655","doi-asserted-by":"crossref","first-page":"958","DOI":"10.4049\/jimmunol.133.2.958","article-title":"Cellular immunity induced by avirulent Salmonella in LPS-defective C3H\/HeJ mice","volume":"133","author":"Eisenstein","year":"1984","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0660","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1046\/j.1365-2567.1997.00158.x","article-title":"Correlates of protection induced by live Aro-Salmonella typhimurium vaccines in the murine typhoid model","volume":"90","author":"Harrison","year":"1997","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0665","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0264-410X(95)00249-Z","article-title":"Protection against oral challenge three months after i.v. immunization of BALB\/c mice with live Aro Salmonella typhimurium and Salmonella enteritidis vaccines is serotype (species)-dependent and only partially determined by the main LPS O antigen","volume":"14","author":"Hormaeche","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0670","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1128\/IAI.47.3.605-612.1985","article-title":"Immunity to Salmonella typhimurium infection in C3H\/HeJ and C3H\/HeNCrlBR mice: studies with an aromatic-dependent live S. typhimurium strain as a vaccine","volume":"47","author":"Killar","year":"1985","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0675","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1365-2958.1997.5601928.x","article-title":"The HtrA family of serine proteases","volume":"26","author":"Pallen","year":"1997","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0680","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1128\/IAI.62.5.1623-1630.1994","article-title":"Salmonella typhimurium loci involved in survival within macrophages","volume":"62","author":"Baumler","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0685","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0882-4010(92)90117-7","article-title":"Evaluation of Salmonella typhimurium strains harbouring defined mutations in htrA and aroA in the murine salmonellosis model","volume":"12","author":"Chatfield","year":"1992","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0690","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1365-2958.1991.tb02122.x","article-title":"The role of a stress-response protein in Salmonella typhimurium virulence","volume":"5","author":"Johnson","year":"1991","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0695","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1128\/IAI.67.2.700-707.1999","article-title":"Characterization of candidate live oral Salmonella typhi vaccine strains harboring defined mutations in aroA, aroC, and htrA","volume":"67","author":"Lowe","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0700","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1128\/IAI.68.1.205-213.2000","article-title":"In vivo characterization of the murine intranasal model for assessing the immunogenicity of attenuated Salmonella enterica serovar Typhi strains as live mucosal vaccines and as live vectors","volume":"68","author":"Pickett","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0705","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1128\/IAI.70.7.3457-3467.2002","article-title":"Characterization of Salmonella enterica derivatives harboring defined aroC and Salmonella pathogenicity island 2 type III secretion system (ssaV) mutations by immunization of healthy volunteers","volume":"70","author":"Hindle","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0710","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1073\/pnas.93.6.2593","article-title":"Identification of a virulence locus encoding a second type III secretion system in Salmonella typhimurium","volume":"93","author":"Shea","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0715","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1046\/j.1365-2958.1998.01048.x","article-title":"Macrophage-dependent induction of the Salmonella pathogenicity island 2 type III secretion system and its role in intracellular survival","volume":"30","author":"Cirillo","year":"1998","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0720","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1046\/j.1365-2958.1998.01047.x","article-title":"Genes encoding putative effector proteins of the type III secretion system of Salmonella pathogenicity island 2 are required for bacterial virulence and proliferation in macrophages","volume":"30","author":"Hensel","year":"1998","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0725","doi-asserted-by":"crossref","first-page":"7800","DOI":"10.1073\/pnas.93.15.7800","article-title":"Identification of a pathogenicity island required for Salmonella survival in host cells","volume":"93","author":"Ochman","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0730","doi-asserted-by":"crossref","first-page":"6036","DOI":"10.1128\/JB.183.20.6036-6045.2001","article-title":"SseBCD proteins are secreted by the type III secretion system of Salmonella pathogenicity island 2 and function as a translocon","volume":"183","author":"Nikolaus","year":"2001","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0735","doi-asserted-by":"crossref","first-page":"5054","DOI":"10.1073\/pnas.86.13.5054","article-title":"A two-component regulatory system (phoP phoQ) controls Salmonella typhimurium virulence","volume":"86","author":"Miller","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0740","doi-asserted-by":"crossref","first-page":"7077","DOI":"10.1073\/pnas.86.18.7077","article-title":"Salmonella typhimurium phoP virulence gene is a transcriptional regulator","volume":"86","author":"Groisman","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0745","doi-asserted-by":"crossref","first-page":"5095","DOI":"10.1128\/IAI.62.11.5095-5101.1994","article-title":"Further characterization of the PhoP regulon: identification of new PhoP-activated virulence loci","volume":"62","author":"Belden","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0750","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1126\/science.2646710","article-title":"A Salmonella locus that controls resistance to microbicidal proteins from phagocytic cells","volume":"243","author":"Fields","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0755","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0882-4010(89)90085-5","article-title":"Virulence and vaccine potential of phoP mutants of Salmonella typhimurium","volume":"6","author":"Galan","year":"1989","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0760","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/0264-410X(93)90006-J","article-title":"The PhoP virulence regulon and live oral Salmonella vaccines","volume":"11","author":"Miller","year":"1993","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0765","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1128\/JB.133.1.149-157.1978","article-title":"Transport of antibiotics and metabolite analogs by systems under cyclic AMP control: positive selection of Salmonella typhimurium cya and crp mutants","volume":"133","author":"Alper","year":"1978","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0770","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1128\/IAI.55.12.3035-3043.1987","article-title":"Salmonella typhimurium deletion mutants lacking adenylate cyclase and cyclic AMP receptor protein are avirulent and immunogenic","volume":"55","author":"Curtiss","year":"1987","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0775","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0378-1135(92)90079-9","article-title":"The effect of exposure to a delta cya\/delta crp mutant of Salmonella typhimurium on the subsequent colonization of swine by the wild-type parent strain","volume":"31","author":"Coe","year":"1992","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0780","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/0923-2508(90)90119-B","article-title":"Control of colonization by virulent Salmonella typhimurium by oral immunization of chickens with avirulent delta cya delta crp S. typhimurium","volume":"141","author":"Hassan","year":"1990","journal-title":"Res Microbiol"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0785","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1128\/IAI.64.3.938-944.1996","article-title":"Effect of vaccination of hens with an avirulent strain of Salmonella typhimurium on immunity of progeny challenged with wild-type Salmonella strains","volume":"64","author":"Hassan","year":"1996","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0790","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1128\/IAI.05278-11","article-title":"Engineering and preclinical evaluation of attenuated nontyphoidal Salmonella strains serving as live oral vaccines and as reagent strains","volume":"79","author":"Tennant","year":"2011","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0795","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1128\/JB.184.3.645-653.2002","article-title":"The ClpXP ATP-dependent protease regulates flagellum synthesis in Salmonella enterica serovar Typhimurium","volume":"184","author":"Tomoyasu","year":"2002","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0800","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1046\/j.1365-2958.2003.03437.x","article-title":"Turnover of FlhD and FlhC, master regulator proteins for Salmonella flagellum biogenesis, by the ATP-dependent ClpXP protease","volume":"48","author":"Tomoyasu","year":"2003","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0805","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1073\/pnas.96.20.11578","article-title":"DNA adenine methylase mutants of Salmonella typhimurium show defects in protein secretion, cell invasion, and M cell cytotoxicity","volume":"96","author":"Garcia-Del Portillo","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0810","doi-asserted-by":"crossref","first-page":"6725","DOI":"10.1128\/IAI.69.11.6725-6730.2001","article-title":"Salmonella DNA adenine methylase mutants confer cross-protective immunity","volume":"69","author":"Heithoff","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0815","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1126\/science.284.5416.967","article-title":"An essential role for DNA adenine methylation in bacterial virulence","volume":"284","author":"Heithoff","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0820","doi-asserted-by":"crossref","first-page":"7197","DOI":"10.1128\/IAI.69.12.7197-7204.2001","article-title":"Roles of DNA adenine methylation in regulating bacterial gene expression and virulence","volume":"69","author":"Low","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0825","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1074\/jbc.M313491200","article-title":"ppGpp-dependent stationary phase induction of genes on Salmonella pathogenicity island 1","volume":"279","author":"Song","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0830","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1016\/j.vaccine.2005.11.031","article-title":"Immune response induced by Salmonella typhimuriumdefective in ppGpp synthesis","volume":"24","author":"Na","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0835","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1006\/mpat.1999.0273","article-title":"Comparison of the abilities of Salmonella typhimurium rpoS, aroA and rpoS aroA strains to elicit humoral immune responses in BALB\/c mice and to cause lethal infection in athymic BALB\/c mice","volume":"26","author":"Coynault","year":"1999","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0840","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2958.1996.tb02664.x","article-title":"Virulence and vaccine potential of Salmonella typhimurium mutants deficient in the expression of the RpoS (sigma S) regulon","volume":"22","author":"Coynault","year":"1996","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0845","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1128\/IAI.05559-11","article-title":"Enterobacterial common antigen mutants of Salmonella enterica serovar Typhimurium establish a persistent infection and provide protection against subsequent lethal challenge","volume":"80","author":"Gilbreath","year":"2012","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0850","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.micpath.2011.02.004","article-title":"Biological and virulence characteristics of Salmonella enterica serovar Typhimurium following deletion of glucose-inhibited division (gidA) gene","volume":"50","author":"Shippy","year":"2011","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0855","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1186\/1471-2180-12-286","article-title":"Immunological characterization of a gidA mutant strain of Salmonella for potential use in a live-attenuated vaccine","volume":"12","author":"Shippy","year":"2012","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0860","doi-asserted-by":"crossref","first-page":"e52043","DOI":"10.1371\/journal.pone.0052043","article-title":"Evaluation of Salmonella enterica serovar Typhimurium TTSS-2 deficient fur mutant as safe live-attenuated vaccine candidate for immunocompromised mice","volume":"7","author":"Vishwakarma","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0865","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.1128\/IAI.65.12.5381-5387.1997","article-title":"Characterization and immunogenicity of Salmonella typhimurium SL1344 and UK-1 delta crp and delta cdt deletion mutants","volume":"65","author":"Zhang","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0870","doi-asserted-by":"crossref","first-page":"4227","DOI":"10.1128\/IAI.05398-11","article-title":"Effect of deletion of genes involved in lipopolysaccharide core and O-antigen synthesis on virulence and immunogenicity of Salmonella enterica serovar Typhimurium","volume":"79","author":"Kong","year":"2011","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0875","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s12275-010-0023-z","article-title":"Immunological responses induced by asd and wzy\/asd mutant strains of Salmonella enterica serovar Typhimurium in BALB\/c mice","volume":"48","author":"Piao","year":"2010","journal-title":"J Microbiol"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0880","doi-asserted-by":"crossref","first-page":"384","DOI":"10.4161\/viru.24886","article-title":"Attenuating gene expression (AGE) for vaccine development","volume":"4","author":"Pascual","year":"2013","journal-title":"Virulence"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0885","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(87)90480-6","article-title":"Large-scale field trial of Ty21a live oral typhoid vaccine in enteric-coated capsule formulation","volume":"1","author":"Levine","year":"1987","journal-title":"Lancet"},{"issue":"Suppl 3","key":"10.1016\/j.vaccine.2015.04.029_bib0890","doi-asserted-by":"crossref","first-page":"S552","DOI":"10.1093\/clinids\/11.Supplement_3.S552","article-title":"Progress in vaccines against typhoid fever","volume":"11","author":"Levine","year":"1989","journal-title":"Rev Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2015.04.029_bib0895","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1086\/518141","article-title":"Ty21a live oral typhoid vaccine and prevention of paratyphoid fever caused by Salmonella enterica Serovar Paratyphi B","volume":"45","author":"Levine","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2015.04.029_bib0900","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1086\/518135","article-title":"CVD 908, CVD 908-htrA, and CVD 909 live oral typhoid vaccines: a logical progression","volume":"45","author":"Tacket","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0905","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/0264-410X(91)90218-U","article-title":"Construction of genetically defined double aro mutants of Salmonella typhi","volume":"9","author":"Hone","year":"1991","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0910","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0264-410X(92)90392-W","article-title":"Clinical acceptability and immunogenicity of CVD 908 Salmonella typhi vaccine strain","volume":"10","author":"Tacket","year":"1992","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0915","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0168-1656(95)00094-1","article-title":"Attenuated Salmonella as live oral vaccines against typhoid fever and as live vectors","volume":"44","author":"Levine","year":"1996","journal-title":"J Biotechnol"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0920","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1172\/JCI115876","article-title":"Evaluation in volunteers of a candidate live oral attenuated Salmonella typhi vector vaccine","volume":"90","author":"Hone","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0925","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1128\/IAI.68.3.1196-1201.2000","article-title":"Phase 2 clinical trial of attenuated Salmonella entericaserovar Typhi oral live vector vaccine CVD 908-htrA in U.S. volunteers","volume":"68","author":"Tacket","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0930","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.1128\/IAI.68.8.4647-4652.2000","article-title":"Constitutive expression of the Vi polysaccharide capsular antigen in attenuated Salmonella enterica serovar Typhi oral vaccine strain CVD 909","volume":"68","author":"Wang","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0935","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1086\/421469","article-title":"Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide","volume":"190","author":"Tacket","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0940","doi-asserted-by":"crossref","first-page":"e11778","DOI":"10.1371\/journal.pone.0011778","article-title":"A randomised trial evaluating the safety and immunogenicity of the novel single oral dose typhoid vaccine M01ZH09 in healthy Vietnamese children","volume":"5","author":"Tran","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0945","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1016\/j.vaccine.2010.02.017","article-title":"In a randomized, double-blinded, placebo-controlled trial, the single oral dose typhoid vaccine, M01ZH09, is safe and immunogenic at doses up to 1.7\u00d710(10) colony-forming units","volume":"28","author":"Lyon","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0950","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1086\/431605","article-title":"The novel oral typhoid vaccine M01ZH09 is well tolerated and highly immunogenic in 2 vaccine presentations","volume":"192","author":"Kirkpatrick","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0955","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1093\/infdis\/173.6.1408","article-title":"phoP\/phoQ-deleted Salmonella typhi (Ty800) is a safe and immunogenic single-dose typhoid fever vaccine in volunteers","volume":"173","author":"Hohmann","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0960","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1016\/j.vaccine.2010.03.019","article-title":"Reactogenicity and immunogenicity of live attenuated Salmonella enterica serovar Paratyphi A enteric fever vaccine candidates","volume":"28","author":"Roland","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0965","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1128\/IAI.05484-11","article-title":"Salmonella enterica serovar Enteritidis core O polysaccharide conjugated to H:g,m flagellin as a candidate vaccine for protection against invasive infection with Salmonella Enteritidis","volume":"79","author":"Simon","year":"2011","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0970","doi-asserted-by":"crossref","first-page":"e64680","DOI":"10.1371\/journal.pone.0064680","article-title":"Sustained protection in mice immunized with fractional doses of Salmonella Enteritidis core and O polysaccharide-flagellin glycoconjugates","volume":"8","author":"Simon","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0975","doi-asserted-by":"crossref","first-page":"5879","DOI":"10.1016\/j.vaccine.2013.09.041","article-title":"Safety and tolerability of a live oral Salmonella Typhimurium vaccine candidate in SIV-infected nonhuman primates","volume":"31","author":"Ault","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0980","doi-asserted-by":"crossref","first-page":"e3394","DOI":"10.1371\/journal.pntd.0003394","article-title":"Invasive Salmonella Typhimurium ST313 with naturally attenuated flagellin elicits reduced inflammation and replicates within macrophages","volume":"9","author":"Ramachandran","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0985","article-title":"Non-typhoidal Salmonella Typhimurium ST313 isolates that cause bacteremia in humans stimulate less inflammasome activation than ST19 isolates associated with gastroenteritis","author":"Carden","year":"2014","journal-title":"Pathog Dis"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0990","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1101\/gr.091017.109","article-title":"Epidemic multiple drug resistant Salmonella Typhimurium causing invasive disease in sub-Saharan Africa have a distinct genotype","volume":"19","author":"Kingsley","year":"2009","journal-title":"Genome Res"},{"key":"10.1016\/j.vaccine.2015.04.029_bib0995","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1046\/j.1365-2958.1998.00984.x","article-title":"Identification of a pathogenicity island required for Salmonella enteropathogenicity","volume":"29","author":"Wood","year":"1998","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2015.04.029_bib1000","doi-asserted-by":"crossref","first-page":"e0003611","DOI":"10.1371\/journal.pntd.0003611","article-title":"Signatures of adaptation in human invasive Salmonella Typhimurium ST313 populations from sub-Saharan Africa","volume":"9","author":"Okoro","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2015.04.029_bib1005","doi-asserted-by":"crossref","first-page":"4881","DOI":"10.1128\/IAI.60.11.4881-4890.1992","article-title":"Characterization and protective properties of attenuated mutants of Salmonella choleraesuis","volume":"60","author":"Kelly","year":"1992","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.04.029_bib1010","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1128\/IAI.67.9.4628-4636.1999","article-title":"Attenuation and immunogenicity of Delta cya Delta crp derivatives of Salmonella choleraesuis in pigs","volume":"67","author":"Kennedy","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.04.029_bib1015","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2460\/ajvr.1995.56.01.39","article-title":"Safety, efficacy, and duration of immunity induced in swine by use of an avirulent live Salmonella choleraesuis-containing vaccine","volume":"56","author":"Roof","year":"1995","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.vaccine.2015.04.029_bib1020","first-page":"91","article-title":"Suisaloral \u201cDessau\u201d \u2013 a Salmonella cholerae suis live vaccine for oral, parenteral and combined applications","volume":"34","author":"Scholl","year":"1980","journal-title":"Arch Exp Veterinarmed"},{"key":"10.1016\/j.vaccine.2015.04.029_bib1025","doi-asserted-by":"crossref","first-page":"8194","DOI":"10.1128\/IAI.73.12.8194-8203.2005","article-title":"Novel attenuated Salmonella enterica serovar Choleraesuis strains as live vaccine candidates generated by signature-tagged mutagenesis","volume":"73","author":"Ku","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.04.029_bib1030","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1099\/00222615-34-1-57","article-title":"Genetic manipulation of Salmonella serotype Bovismorbificans to aromatic-dependence and evaluation of its vaccine potential in mice","volume":"34","author":"Mukkur","year":"1991","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.vaccine.2015.04.029_bib1035","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1128\/IAI.55.4.955-962.1987","article-title":"Test of the virulence and live-vaccine efficacy of auxotrophic and galE derivatives of Salmonella choleraesuis","volume":"55","author":"Nnalue","year":"1987","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.04.029_bib1040","doi-asserted-by":"crossref","first-page":"7950","DOI":"10.1128\/IAI.69.12.7950-7954.2001","article-title":"Salmonella DNA adenine methylase mutants elicit protective immune responses to homologous and heterologous serovars in chickens","volume":"69","author":"Dueger","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.04.029_bib1045","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0882-4010(91)90075-L","article-title":"Immunity conferred by Aro-Salmonella live vaccines","volume":"10","author":"Hormaeche","year":"1991","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2015.04.029_bib1050","first-page":"16","article-title":"Cross-protection against Salmonella Typhimurium infection conferred by a live attenuated Salmonella Enteritidis vaccine","volume":"79","author":"Nandre","year":"2015","journal-title":"Can J Vet Res"},{"key":"10.1016\/j.vaccine.2015.04.029_bib1055","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1574-695X.2000.tb01508.x","article-title":"Salmonella enteritidis temperature-sensitive mutants protect mice against challenge with virulent Salmonella strains of different serotypes","volume":"29","author":"Gherardi","year":"2000","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2015.04.029_bib1060","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1099\/jmm.0.000014","article-title":"Mouse models for assessing the cross-protective efficacy of oral non-typhoidal Salmonella vaccine candidates harbouring in-frame deletions of the ATP-dependent protease lon and other genes","volume":"64","author":"Matsui","year":"2015","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.vaccine.2015.04.029_bib1065","doi-asserted-by":"crossref","first-page":"7238","DOI":"10.1016\/j.vaccine.2012.10.002","article-title":"Live oral typhoid vaccine Salmonella Typhi Ty21a \u2013 a surrogate vaccine against non-typhoid salmonella?","volume":"30","author":"Kantele","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.04.029_bib1070","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1128\/CVI.00786-13","article-title":"Live oral Salmonella enterica serovar Typhi vaccines Ty21a and CVD 909 induce opsonophagocytic functional antibodies in humans that cross-react with Salmonella Paratyphi A and S. Paratyphi B","volume":"21","author":"Wahid","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2015.04.029_bib1075","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1128\/CVI.00058-12","article-title":"Live oral typhoid vaccine Ty21a induces cross-reactive humoral immune responses against Salmonella enterica serovar Paratyphi A and S. Paratyphi B in humans","volume":"19","author":"Wahid","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2015.04.029_bib1080","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1128\/CDLI.12.9.1127-1129.2005","article-title":"Comparison of the antibodies in lymphocyte supernatant and antibody-secreting cell assays for measuring intestinal mucosal immune response to a novel oral typhoid vaccine (M01ZH09)","volume":"12","author":"Kirkpatrick","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2015.04.029_bib1085","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.vaccine.2005.08.008","article-title":"Evaluation of Salmonella enterica serovar Typhi (Ty2 aroC-ssaV-) M01ZH09, with a defined mutation in the Salmonella pathogenicity island 2, as a live, oral typhoid vaccine in human volunteers","volume":"24","author":"Kirkpatrick","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.04.029_bib1090","first-page":"565","article-title":"M-01ZH09, an oral live attenuated Salmonella enterica serovar Typhi vaccine for the prevention of typhoid fever","volume":"11","author":"Jain","year":"2009","journal-title":"Curr Opin Mol Ther"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1500482X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1500482X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T13:39:20Z","timestamp":1717853960000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1500482X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":109,"alternative-id":["S0264410X1500482X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.04.029","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Live attenuated vaccines for invasive Salmonella infections","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.04.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}